| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-12 02:38:34 UTC |
|---|
| Update Date | 2023-02-21 17:28:32 UTC |
|---|
| HMDB ID | HMDB0041011 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | beta-Cyclocitral |
|---|
| Description | beta-Cyclocitral, also known as β-cyclocitral, belongs to the class of organic compounds known as organic oxides. These are organic compounds containing an oxide group. beta-Cyclocitral is a sweet, clean, and damascone tasting compound. beta-Cyclocitral is found, on average, in the highest concentration within orange mints (Mentha aquatica) and safflowers (Carthamus tinctorius). beta-Cyclocitral has also been detected, but not quantified in, several different foods, such as garden tomatoes (Solanum lycopersicum), garden tomato (var.), teas (Camellia sinensis), black tea, and cauliflowers (Brassica oleracea var. botrytis). This could make beta-cyclocitral a potential biomarker for the consumption of these foods. beta-Cyclocitral is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a small amount of articles have been published on beta-Cyclocitral. |
|---|
| Structure | InChI=1S/C10H16O/c1-8-5-4-6-10(2,3)9(8)7-11/h7H,4-6H2,1-3H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 2,6,6-Trimethyl-1-cyclohexene-1-carboxaldehyde | ChEBI | | 2,6,6-Trimethyl-1-cyclohexene-1-carbaldehyde | Kegg | | b-Cyclocitral | Generator | | Β-cyclocitral | Generator | | 1-Formyl-2,6,6-trimethyl-1-cyclohexene | HMDB | | 2,6,6-Trimethyl-1-cyclohexen-1-carboxaldehyde | HMDB | | 2,6,6-Trimethyl-cyclohexene-1-carboxaldehyde | HMDB | | 2,6,6-Trimethyl-cyclohexenecarboxaldehyde | HMDB | | 2,6,6-Trimethylcyclohex-1-ene-1-carbaldehyde | HMDB | | 2,6,6-Trimethylcyclohexene-1-carbaldehyde | HMDB | | 2,6,6-Trimethylcyclohexenecarbaldehyde | HMDB | | alpha(beta)-Cyclocitral | HMDB | | beta -Cyclocitral | HMDB | | beta-Cyclocitrol | HMDB |
|
|---|
| Chemical Formula | C10H16O |
|---|
| Average Molecular Weight | 152.2334 |
|---|
| Monoisotopic Molecular Weight | 152.120115134 |
|---|
| IUPAC Name | 2,6,6-trimethylcyclohex-1-ene-1-carbaldehyde |
|---|
| Traditional Name | β-cyclocitral |
|---|
| CAS Registry Number | 432-25-7 |
|---|
| SMILES | CC1=C(C=O)C(C)(C)CCC1 |
|---|
| InChI Identifier | InChI=1S/C10H16O/c1-8-5-4-6-10(2,3)9(8)7-11/h7H,4-6H2,1-3H3 |
|---|
| InChI Key | MOQGCGNUWBPGTQ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as organic oxides. These are organic compounds containing an oxide group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organic oxides |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Organic oxides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aldehyde
- Aliphatic homomonocyclic compound
|
|---|
| Molecular Framework | Aliphatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | |
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.71 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 17.1712 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.76 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2165.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 604.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 224.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 385.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 253.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 706.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 813.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 154.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1352.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 479.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1519.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 509.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 430.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 568.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 646.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 26.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - beta-Cyclocitral EI-B (Non-derivatized) | splash10-0l0i-4900000000-f6c4a4fe93d19741cab0 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - beta-Cyclocitral EI-B (Non-derivatized) | splash10-0l0i-4900000000-f6c4a4fe93d19741cab0 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - beta-Cyclocitral GC-MS (Non-derivatized) - 70eV, Positive | splash10-052r-3900000000-6391af660fd4d8a21547 | 2016-09-22 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - beta-Cyclocitral GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-052o-9300000000-be54b6f8155405712fdf | 2015-03-01 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 10V, Positive-QTOF | splash10-0udi-1900000000-a06d949d55e95a72b6b7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 20V, Positive-QTOF | splash10-0udi-9800000000-19d87f66741a50d0e677 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 40V, Positive-QTOF | splash10-0gb9-9100000000-9690930ec35bca459333 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 10V, Negative-QTOF | splash10-0udi-0900000000-dcfa64ac0ff4ae18463b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 20V, Negative-QTOF | splash10-0udi-0900000000-6237aac949530326cbf1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 40V, Negative-QTOF | splash10-0kmr-3900000000-5d5d6b808dcc3a96c3e3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 10V, Positive-QTOF | splash10-0udi-6900000000-10632e4d0107c6bea634 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 20V, Positive-QTOF | splash10-0arr-9200000000-06e9f20fa2dfd319b3ba | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 40V, Positive-QTOF | splash10-067i-9100000000-eec8f7754558ce99427a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 10V, Negative-QTOF | splash10-0uk9-0900000000-242103d291e18a765c21 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 20V, Negative-QTOF | splash10-0fk9-0900000000-64f4832ef5436e56e9ff | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cyclocitral 40V, Negative-QTOF | splash10-0a4i-0900000000-a4b505d5001ef400c380 | 2021-09-23 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-04 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-04 | FELIX lab | View Spectrum |
|
|---|
| Disease References | | Nonalcoholic fatty liver disease |
|---|
- Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, Bailey J, Myers RP, Rioux KP: Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3. doi: 10.1016/j.cgh.2013.02.015. Epub 2013 Feb 27. [PubMed:23454028 ]
|
|
|---|